Scarlet Therapeutics, a leader in red blood cell-based therapeutics (tRBCs), has launched with seed funding from Science Creates Ventures and Meltwind to further develop its platform.  Born out of more than a decade of research at the University of Bristol and spearheaded by Professors Ashley Toye and Jan Frayne, with CEO Alistair Irvine at the […]